J. Deininger

发表

Absence of Skp2 Expression Attenuates Bcr-abl-induced

K. Nakayama, B. Druker, A. Corbin, 2008 .

neoplasms normalizes inflammatory cytokines in murine myeloproliferative CYT387, a novel JAK2 inhibitor, induces hematologic responses and

B. Druker, M. Deininger, J. Tyner, 2011 .

CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms.

B. Druker, M. Deininger, J. Tyner, 2010, Blood.

Characterization of murine JAK2V617F-positive myeloproliferative disease.

B. Druker, A. Corbin, M. Deininger, 2006, Cancer research.

Protein kinase A RII-like (R2D2) proteins exhibit differential localization and AKAP interaction.

C. Corless, Jieyan Pan, D. Carr, 2008, Cell motility and the cytoskeleton.

Absence of SKP 2 expression attenuates BCR-ABL-induced

K. Nakayama, B. Druker, A. Corbin, 2008 .

Clonal chromosomal abnormalities in CD34+/CD38− hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors

B. Druker, M. Deininger, M. Mauro, 2010, Leukemia.

Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.

K. Nakayama, B. Druker, A. Corbin, 2008, Blood.

Effects of CYT387, a potent novel JAK2 inhibitor on JAK2-V617F induced MPD

B. Druker, M. Deininger, J. Tyner, 2008 .